About Owkin
Owkin is a company based in Paris (France) founded in 2016 by Gilles Wainrib and Thomas Clozel. It operates as a AI-as-a-Service, Professional Services, and HealthTech. Owkin has raised $321.1 million across 12 funding rounds from investors including Sanofi, Mubadala and Plug and Play Tech Center. Owkin offers products and services including Owkin K Pro, Owkin K Navigator, MSIntuit® CRC, and RlapsRisk® BC. Owkin operates in a competitive market with competitors including Formation Bio, BigHat, Benchsci, Predictive Oncology and Iambic Therapeutics, among others.
- Headquarter Paris, France
- Founders Gilles Wainrib, Thomas Clozel
- Stage Unicorn
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Owkin, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$321.1 M (USD)
in 12 rounds
-
Latest Funding Round
$216.35 K (USD), Grant
Jan 01, 2023
-
Investors
Sanofi
& 18 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Owkin
Owkin offers a comprehensive portfolio of products and services, including Owkin K Pro, Owkin K Navigator, MSIntuit® CRC, and RlapsRisk® BC. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Agentic AI tool for biopharma decision-making support.
AI co-pilot for biomedical research and exploration.
AI tool for optimizing colorectal cancer MSI testing.
AI assesses relapse risk in early breast cancer.
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Senior Team
16 people
Software Development Team
14 people
Sales and Marketing
12 people
Human Resources and Administration
11 people
Scientific Team
9 people
Operations Team
9 people
Product Management Team
8 people
Unlock access to complete
Funding Insights of Owkin
Owkin has successfully raised a total of $321.1M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $216.35 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $216,355
-
First Round
First Round
(01 Nov 2016)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Grant - Owkin | Valuation |
investors |
|
| Jun, 2022 | Amount | Series B - Owkin | Valuation |
investors |
|
| Nov, 2021 | Amount | Series B - Owkin | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Owkin
Owkin has secured backing from 19 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Sanofi, Mubadala and Plug and Play Tech Center. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in technology startups through a global ecosystem.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Owkin
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Owkin
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Owkin Comparisons
Competitors of Owkin
Owkin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, BigHat, Benchsci, Predictive Oncology and Iambic Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery platform for the treatment of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Owkin
Frequently Asked Questions about Owkin
When was Owkin founded?
Owkin was founded in 2016.
Where is Owkin located?
Owkin is headquartered in Paris, France.
Who is the current CEO of Owkin?
Thomas Clozel is the current CEO of Owkin. They have also founded this company.
Is Owkin a funded company?
Owkin is a funded company, having raised a total of $321.1M across 12 funding rounds to date. The company's 1st funding round was a Series B of $180M, raised on Nov 01, 2016.
What does Owkin do?
Owkin is engaged in transforming healthcare by leveraging agentic AI to understand complex biology. The company is involved in drug discovery, development, and diagnostics within the biopharma and healthcare sectors. Solutions are developed to process vast biological data, uncover hidden relationships, and generate actionable insights. Multimodal patient data is accessed from diverse populations through partnerships with top academic institutions. Owkin K, an AI platform, is utilized to drive decision-making and accelerate breakthroughs across various teams. Additionally, diagnostic tools are provided for precision pathology in oncology, supporting clinical trials and routine clinical use.
Who are the top competitors of Owkin?
Owkin's top competitors include Formation Bio, XtalPi and Benchsci.
What products or services does Owkin offer?
Owkin offers Owkin K Pro, Owkin K Navigator, MSIntuit® CRC, and RlapsRisk® BC.
Who are Owkin's investors?
Owkin has 19 investors. Key investors include Sanofi, Mubadala, Plug and Play Tech Center, Bpifrance, and European Union.
What is Owkin's valuation?
The valuation of Owkin is $1B as of Nov 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.